Importance of Percutaneous Endoscopic Gastrostomy (PEG) in Nutritional Management of Patients with Advanced Head and Neck Cancer
Kazunobu Asano,Osamu Tanaka,Yasunori Muramatsu
DOI: https://doi.org/10.1093/cdn/nzaa055_001
2020-05-29
Current Developments in Nutrition
Abstract:Abstract Objectives Chemoradiotherapy (CRT) is well established treatment for the head and neck cancer. Patients undergoing CRT often have adverse effects, resulting reduced oral intake, weight loss and malnutrition. Body weight is a life prognostic factor. Thus, proper body weight control is essential for treatment completion. From April 2019, we started nutritional management using PEG. After then, we have seen cases in which weight control was better in tube feeding with PEG than with conventional method. In this case study, we present benefit of tube feeding with PEG to maintain body weight in head neck cancer patients underwent CRT. Methods Five subjects underwent CRT for head and neck cancer were selected. The conventional method were provided for subject 1 and 2 (group A). Subject 3, 4, and 5 were underwent tube feeding with PEG (group B). Energy and protein requirements were calculated at admission. The average daily nutritional sufficiency was calculated for subject 1, 2, 3, and 5. Changes in body weight, arm circumference (AC), and calf circumference (CC), and controlling nutritional status (CONUT) scores at admission and at discharge were compared. Results The daily energy and protein intake sufficiency rates in subject 1, 2, 3, and 5 were as follow; 84.8%, 54.6%, 105.4%, and 114.7% for energy intake, and 89.5%, 47.5%, 112.2%, and 122.7% for protein intake. Change in body weight were −13.3% and −17.6% in group A, and −8.7%, −4.9%, and +4.7% in group B. The greater the energy intake sufficiency rate was, the more weight could be maintained. Subject 2 and 3 were weighed several months after discharge. Subject 2 had further weight loss of −11.9%. In contrary, subject 3 gained 13.9% of weight. He gained weight by continuous intake of enough nutrients with PEG. AC were −13.9% and −2.1% in group A, and −13.2%, −0.9% and −1.2% in group B. CC were −3.3% and −7.8% in group A, and 0.3%, −0.7%, and −2.2% in group B. The tube feeding with PEG enabled to provide sufficient nutrients to suppress muscle loss. The pre-treatment CONUT score was ‘normal’ in all subjects. The CONUT score at discharge were ‘light’ for subject 2 and 3, ‘moderate’ for subject 1, 4, and 5. No association between weight loss and the CONUT score was seen in these subjects. Conclusions PEG was suggested to contribute to good weight control and nutritional management in head and neck cancer treatment. Funding Sources Asahi University Hospital.